The clinical and prognostic use of circulating tumour cells in breast cancer
Adjuvant therapies such as endocrine or cytotoxic chemotherapy have been demonstrated to improve overall survival in early breast cancer patients. A blood test to monitor patients at risk of relapse is needed to identify those patients who would benefit from these treatments and those for whom it is...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2011
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.537204 |